Navigation Links
NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
Date:10/30/2009

SAN MATEO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will hold a conference call on Friday, November 6, 2009 at 9:00 a.m. ET (6:00 a.m. PT) to report results for its third quarter 2009.

The conference call will be hosted by Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, Chief Financial Officer.

To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International). To access the live web cast please visit the Investor Relations section on the corporate web site at http://www.neurogesx.com.

A replay of the conference call will be available beginning November 6, 2009 at 7:30 p.m. ET (4:30 p.m. PT) and ending on November 16, 2009 by dialing 1-877-660-6853 (USA) or 1-201-612-7415 (International), Account Number: 3055, Conference ID Number: 336156. A replay of the webcast will also be available on the corporate website for one month, through December 6, 2009.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatmen
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. NeurogesX to Present at JMP Securities Healthcare Focus Conference
2. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
3. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
4. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
5. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
6. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
7. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
8. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
9. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Beckman Coulter Announces Conference Call and Webcast of Accompanying Slides in Conjunction With Third Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Mass. , Feb. 9 STD Med, ... Stoughton, Massachusetts is pleased to announce the acquisition ... Bridgewater, Massachusetts . This is in addition to the current ... growing and advancing the company during these difficult financial times," ... this growth to the premise on which STD Med was ...
(Date:2/9/2010)... , Feb. 9 Volcano ... and manufacturer of precision intravascular therapy guidance tools ... coronary and peripheral vascular disease, announced today that ... device line from Lumen Biomedical. Volcano became the ... May 2009 . This acquisition reinforces Volcano,s ...
(Date:2/9/2010)... Calif. , Feb. 9 ... announced financial guidance for the full year 2010. ... $147 to $165 million .  In addition, ... in 2010, with earnings per share for the ... $0.02 , excluding any mark-to-market adjustments relating to ...
Breaking Medicine Technology:STD Med Inc. Acquires Facility for Manufacturing and Start-Ups 2Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 2Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 3Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 4Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 5ISTA Pharmaceuticals Announces 2010 Financial Guidance 2ISTA Pharmaceuticals Announces 2010 Financial Guidance 3ISTA Pharmaceuticals Announces 2010 Financial Guidance 4ISTA Pharmaceuticals Announces 2010 Financial Guidance 5Alcohol consumption may increase breast cancer recurrence risk 63050 1Alcohol consumption may increase breast cancer recurrence risk 63050 2Potential new heart attack biomarker uncovered 11085 1Potential new heart attack biomarker uncovered 11085 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 15138 1Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 15138 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 15138 3
... - King,Pharmaceuticals, Inc. (NYSE:KG) reported today that ... Altace (ramipril) 20mg and the,combination of ALTACE ... weekend at the American Society of Hypertension,Inc. ... 2007) in Chicago, Illinois. The clinical trial ...
... being presented today at Digestive Disease Week -, ... today,announced the presentation of data from a Phase ... improved bowel function,in patients with constipation- predominant irritable ... well tolerated with,a low incidence of adverse events. ...
Other Medicine Technology:King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 2King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 3King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 4King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 5Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4
(Date:2/9/2010)... The following statement is attributable ... President, American Medical Association: ,, (Logo: ... Association is pleased to support First Lady ... Move Campaign. As the nation,s largest physician ... obesity and are committed to reenergizing our ...
(Date:2/9/2010)... Cancer Institute and the Sanford-Burnham Medical Research Institute ... wholly owned member of the Roche group, and ... manufacture, develop and market human monoclonal antibodies to ... These viruses include the strains for the current ... have a non-exclusive right to manufacture, develop and ...
(Date:2/9/2010)... their skins, but some restaurants and population groups also ... eating these animals can have side effects that call ... Parasites, bacteria and viruses, and to a lesser extent ... eating reptile meat can cause several problems to health. ... the International Journal of Food Microbiology , which ...
(Date:2/9/2010)... Rhonda Roby , PhD, ... University of North Texas Center for Human Identification ... in recently identifying three murder victims of the Chilean ... The Chilean government contacted Roby in 2006 ... team of the victims, identification program for Patio 29. ...
(Date:2/9/2010)... Dr. Franois Robert, a researcher at the Institut de ... team of Dr. Daniel Durocher (Samuel Lunenfeld Research Institute ... mapped all the fragile sites of a living organism, ... used by the researchers can be applied to humans. ... scientific journal Nature Structural and Molecular Biology . ...
Breaking Medicine News(10 mins):Health News:Study carried out into biological risks of eating reptiles 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 3Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3
... of all family caregivers of Alzheimer,s disease patients succumb ... one and become hospital patients themselves, according to an ... of the Journal of General Internal Medicine . ... Medicine, the Regenstrief Institute and the Indiana University Center ...
... Key Factors Related to Online Detailing,s Significant ... /PRNewswire-FirstCall/ - According to an analysis of,physician prescribing ... leading provider of physician access through its innovative ... "highest value" to a,major pharmaceutical company participated in ...
... of Regence workers participate in annual giving effort, ... campaign record and bucked a national trend that threatens,charitable ... outlook -- or perhaps because of it --,Regence employees ... the company,s 50 percent match, local communities will,receive a ...
... Scientists from Maastricht University have developed a method to look ... has spoken to him or her and what was said. ... researchers mapped the brain activity associated with the recognition of ... "Who" is Saying "What"? Brain-Based Decoding of Human Voice and ...
... But study questions if MRIs, CT scans are always worth ... use of MRI and CT scanners in the United States ... resulted in better health care or fewer deaths, according to ... The researchers analyzed Medicare claims data and found that the ...
... wellness services to internal medicine, combining nutrition, education, fitness planning, ... ... one location., PHILADELPHIA, Nov. 10 Doctor Leslie Saltzman ... Wellness Center, the first primary medical care outpatient center,offering integrated ...
Other Medicine News:Health News:Caring for the caregiver: Redefining the definition of patient 2Health News:New Survey Indicates "Highest-Value" Physicians Most Likely to Participate in Aptilon's Live Video Detailing Service 2Health News:New Survey Indicates "Highest-Value" Physicians Most Likely to Participate in Aptilon's Live Video Detailing Service 3Health News:Trend-Breaking Employee Campaign Raises Nearly $2.5 Million 2Health News:Maastricht University researchers produce 'neural fingerprint' of speech recognition 2Health News:Use of Imaging Technology Skyrockets 2Health News:Use of Imaging Technology Skyrockets 3Health News:Rittenhouse Women's Wellness Center: Internal Medicine plus Nutrition, Fitness, Emotional Well-Being and Skin Care 2
... Neonates to adults, the entire series of ... knowledge of the needs of care providers ... in the accuracy. You can see it ... in the performance, year after year. Every ...
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
Medicine Products: